Rapid Micro Biosystems Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-52.47	-60.81	-78.03	-45.22	-26.62
Depreciation & Amortization	4.31	3.98	1.53	1.51	1.46
Share-Based Compensation	4.75	4.02	1.84	0.53	0.47
Other Operating Activities	-1.67	-5.74	15.19	4.04	-1.91
Operating Cash Flow	-45.08	-58.55	-54.96	-31	-21.15
Capital Expenditures	-1.85	-6.74	-3.2	-0.69	-1.7
Change in Investments	44	-86.73	-10.09	-14.98	0
Investing Cash Flow	42.15	-93.47	-13.29	-15.67	-1.7
Share Issuance / Repurchase	0.19	0.73	165.04	0.07	0.01
Debt Issued / Paid	-0.04	-0.03	-26.17	15.63	0
Other Financing Activities	-	-	77.88	48.54	14.86
Financing Cash Flow	0.15	0.69	216.75	64.23	14.87
Net Cash Flow	-2.78	-151.32	148.49	17.57	-7.97
Free Cash Flow	-46.93	-65.29	-58.16	-31.69	-22.84
Free Cash Flow Margin	-208.38%	-381.06%	-250.35%	-197.09%	-138.34%
Free Cash Flow Per Share	-1.09	-1.54	-2.94	-88.36	-13.16

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).